Azaguanine-8: Properties, Applications & Handling Guidelines

Azaguanine-8 is a purine nucleobase analog that acts as a selective inhibitor of hypoxanthine-guanine phosphoribosyltransferase (HGPRT), widely used in cell biology for mutant cell selection and hybridoma technology.

Chemical Name

8-Azaguanine (2-amino-1H-purin-6(9H)-one with nitrogen substitution at position 8)

Molecular Formula

C₄H₄N₆O

Primary Mechanism

Incorporated via HGPRT into nucleotide pools, causing cytotoxicity; cells lacking HGPRT activity survive selection.

Key Application

Selection of HGPRT-deficient mutant cells; hybridoma and somatic cell genetics research.

Solubility

Sparingly soluble in water; soluble in dilute base or DMSO with warming.

Storage Condition

Store at room temperature (15–25 °C), protected from light and moisture.

Chemical Identity and Physical Properties

Azaguanine-8 (8-azaguanine) is a structural analog of the purine nucleobase guanine, in which the carbon atom at position 8 of the purine ring is replaced by a nitrogen atom. Its molecular formula is C₄H₄N₆O, and it possesses a molecular weight of approximately 152.12 g/mol. The compound appears as a white to off-white crystalline powder at ambient conditions.

Azaguanine-8 exhibits limited aqueous solubility under neutral pH. Dissolution is facilitated by the use of dilute sodium hydroxide solution (0.1 M NaOH) or by dissolving in DMSO with gentle warming, followed by dilution into aqueous buffer. Stock solutions should be prepared fresh or stored at −20 °C to minimise degradation. Researchers should verify solubility and concentration by UV absorbance, as 8-azaguanine has a characteristic absorbance maximum in the ultraviolet region near 310 nm under alkaline conditions.

Mechanism of Action and Biological Activity

Azaguanine-8 exerts its cytotoxic effects through the salvage purine synthesis pathway. In cells expressing functional hypoxanthine-guanine phosphoribosyltransferase (HGPRT), azaguanine-8 is recognised as a substrate and phosphoribosylated to the corresponding nucleotide analog. This fraudulent nucleotide is incorporated into RNA and DNA, disrupting nucleic acid function and ultimately causing cell death.

Cells that have lost HGPRT activity—whether through spontaneous mutation, chemical mutagenesis, or genetic engineering—are unable to process azaguanine-8 via the salvage pathway. Such HGPRT-deficient cells therefore survive exposure to azaguanine-8, which is the basis of its use as a positive selection agent. This principle underpins the HAT (hypoxanthine–aminopterin–thymidine) and related selection systems central to hybridoma technology and somatic cell genetics.

Research Applications and Experimental Use

The primary research application of Azaguanine-8 is the selection of HGPRT-deficient cell lines. These cell lines serve as essential parental fusion partners in hybridoma production: when fused with antibody-secreting B cells in the presence of HAT medium, only successfully fused hybrids survive, because unfused HGPRT⁻ myeloma cells are killed by HAT and unfused B cells have a limited lifespan.

Beyond hybridoma technology, azaguanine-8 is used in mutagenicity assays (e.g., the HPRT forward mutation assay) to quantify the frequency of induced mutations at the HPRT locus. It is also employed in somatic cell genetics to study gene dosage, X-chromosome inactivation, and purine metabolism disorders. Researchers in pharmacology use HGPRT-deficient cells generated with azaguanine-8 as tools to evaluate drug resistance mechanisms.

Typical working concentrations range from 10–100 µM depending on the cell line and experimental design; users should optimise kill-curve conditions empirically before initiating selection experiments.

Safe Handling, Storage and Disposal

Azaguanine-8 is a cytotoxic compound and should be handled with appropriate personal protective equipment (PPE), including nitrile gloves, a laboratory coat, and eye protection. All manipulations producing dust or aerosols should be conducted inside a fume hood or biological safety cabinet. Avoid inhalation of powder or mist and prevent contact with skin, eyes, and mucous membranes.

Store the solid compound at room temperature (15–25 °C) in a tightly sealed container, protected from light, heat, and moisture. Solutions prepared in DMSO or aqueous base should be aliquoted and stored at −20 °C for short-term use; avoid repeated freeze–thaw cycles.

Dispose of waste material in accordance with institutional biosafety guidelines and applicable local regulations for hazardous chemical waste. Do not dispose of azaguanine-8 solutions down the drain. Consult the Safety Data Sheet (SDS) for full hazard information before use.

Quality, Purity and Ordering Information

Aladdin Scientific supplies Azaguanine-8 (SKU: A129567) as a research-grade reagent. Lot-specific certificates of analysis (CoA) documenting purity, appearance, and analytical data are available on request or via the product page. Researchers are encouraged to review the CoA before use to confirm compliance with experimental requirements.

For procurement inquiries, bulk quantities, or custom packaging, please contact Aladdin Scientific's customer service team. Volume pricing and institutional purchasing agreements may be available. Ensure that all regulatory and import requirements are met when ordering internationally.

Frequently asked questions

What is the recommended working concentration of Azaguanine-8 for selecting HGPRT-deficient cells?

Typical working concentrations range from 10 to 100 µM, but the optimal concentration varies by cell line. It is strongly recommended to perform a kill-curve experiment with wild-type HGPRT-positive cells to determine the minimum concentration that achieves complete cell death within 5–7 days before beginning selection.

How should Azaguanine-8 stock solutions be prepared and stored?

Azaguanine-8 is sparingly soluble in water at neutral pH. Dissolve the compound in 0.1 M NaOH or warm DMSO, then dilute to the desired concentration in cell culture medium or aqueous buffer. Aliquot solutions and store at −20 °C, protected from light. Avoid repeated freeze–thaw cycles to maintain integrity.

Can Azaguanine-8 be used in the HPRT forward mutation assay?

Yes, Azaguanine-8 is a well-established selective agent for the HPRT (hypoxanthine-guanine phosphoribosyltransferase) forward mutation assay. Cells that have acquired a loss-of-function mutation at the HPRT locus resist azaguanine-8 cytotoxicity and form colonies, enabling quantification of mutation frequency induced by genotoxic agents.

Is Azaguanine-8 hazardous, and what PPE is required?

Azaguanine-8 is a cytotoxic compound and should be treated as a potential chemical hazard. Wear nitrile gloves, a laboratory coat, and safety goggles when handling. Powder manipulations should be performed in a fume hood. Consult the Safety Data Sheet (SDS) provided with the product for complete hazard, first-aid, and disposal information.

References

1. Littlefield JW. Selection of hybrids from matings of fibroblasts in vitro and their presumed recombinants. Science. 1964;145(3633):709–710.
2. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256(5517):495–497.
3. Stout JT, Caskey CT. HPRT: gene structure, expression, and mutation. Annual Review of Genetics. 1985;19:127–148.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.